Caldera said that its research and development capabilities have been enhanced with specialised lab and prototype development areas, allowing for acceleration of product portfolio activities.

In addition, the move will provide the women’s health medical device company with the ability to consolidate all corporate operations in a single location.

Caldera chairman and CEO Bryon Merade said that given their growth, it became critical to realize an increase in operating efficiencies and not only will the new facility allow to meet the growing demand for the company’s products, but it will also allow them to more effectively build out supporting in-house infrastructure for the rapidly growing organization.